Skip to main content
. 2022 Apr 28;9:870847. doi: 10.3389/fcvm.2022.870847

TABLE 1.

Sample characteristics.

Without cardiovascular disease (N = 360)
With cardiovascular disease (N = 99)
Male
(N = 187)
Female
(N = 173)
Male
(N = 71)
Female
(N = 28)
Age [years] 49.0 ± 18.3 51.2 ± 19.0 68.5 ± 12.5* 72.0 ± 13.4*
V.O2peak [ml/min/kg] 40.5 ± 9.5 32.4 ± 8.0 24.9 ± 8.5* 19.4 ± 5.9*
BMI [kg/m2] 24.0 ± 2.4 22.6 ± 2.5 27.3 ± 3.5* 25.5 ± 3.3*
MAP [mmHg] 94.9 ± 8.2 91.1 ± 9.5 97.3 ± 10.8 97.7 ± 10.7*
HbA1c [%] 5.2 ± 0.3 5.2 ± 0.4 5.8 ± 0.6* 5.6 ± 0.4*
Triglycerides [mg/dL] 131.3 ± 71.5 99.8 ± 48.9 125.8 ± 73.1 140.5 ± 88.8*
LDL-cholesterol [mg/dL] 118.2 ± 25.9 123.6 ± 29.2 101.4 ± 31.4* 123.6 ± 31.1
hs-CrP [mg/L] 1.8 ± 4.1 1.9 ± 3.7 3.0 ± 3.8* 2.5 ± 2.0
Creatinine [mg/L] 0.9 ± 0.1 1.3 ± 0.8 1.1 ± 0.4* 0.8 ± 0.2
NT-pro-BNP [pg/mL] 77.9 ± 75.1 128.5 ± 96.1 468.1 ± 667.3* 564.8 ± 829.5*
FMD [%] 6.6 ± 4.0 7.8 ± 4.3 4.6 ± 3.2* 4.3 ± 3.5*
L-FMC [%] −0.6 ± 2.8 −0.7 ± 3.1 −0.3 ± 2.0 −1.2 ± 3.0
Pre-cuff-infl. diam. [mm] 4.2 ± 0.5 3.4 ± 0.4 4.4 ± 0.6 3.7 ± 0.6*
Resting heart rate [bpm] 57.1 ± 9.2 58.7 ± 8.6 58.4 ± 8.9 61.5 ± 9.8

V.O2peak = peak oxygen consumption; BMI = Body mass index; MAP = Mean arterial pressure; HbA1c = glycated hemoglobin; LDL-cholesterol = Low-density lipoprotein-cholesterol; hs-CrP = high-sensitivity C-reactive protein; NT-pro-BNP = n-terminal-pro-brain natriuretic peptide; FMD = flow-mediated vasodilation; L-FMC = low flow-mediated vasoconstriction; Pre-cuff-infl. diam. = pre-cuff-inflation diameter; *significantly different from “without cardiovascular disease” (independent student’s t-test, significance level p = 0.05).